Partner Content Partner Content PLIVA explores impact of EU Guidelines on evaluation of modi... PLIVA explores EU Guidelines for modified release drugs
Partner Content Partner Content The 10th Annual Social Media in Pharma – Exclusive Speaker I... Social Media in Pharma
News Takeda depression app impresses in pilot study App corresponds with standard cognitive and patient-reported assessment measures.
Views & Analysis Exclusive live coverage: Frontiers Health 2017 What does the cutting-edge of digital health look like? Which innovations are on the cusp of becoming a mainstream reality and who is it that is driving this advancement?
News Fitbit selected as part of NIH precision medicine programme 10,000 Fitbit devices will be used as part of pilot study.
Events Partner Content 10th annual Adaptive Designs in Clinical Trials Adaptive Designs in Clinical Trials 2018
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.